Response of fistulating Crohn's disease to infliximab treatment assessed by magnetic resonance imaging

Alimentary Pharmacology and Therapeutics

Volumn 17, Issue 3, 2003, Pages 387-393

  Bell, S J ^a   Halligan, S ^a   Windsor, A C J ^a   Williams, A B ^a   Wiesel, P ^a   Kamm, M A ^a  

^a ST MARK S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; INFLIXIMAB;

ADULT; ANUS FISTULA; ARTICLE; CLINICAL ARTICLE; CLINICAL EXAMINATION; CONTROLLED STUDY; CROHN DISEASE; DRUG EFFICACY; DRUG INFUSION; ENTERIC FEEDING; ENTEROCUTANEOUS FISTULA; FEMALE; HEALING; HUMAN; ILEOSTOMY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOMES RESEARCH; PERIANAL ABSCESS; PRIORITY JOURNAL; RECTOVAGINAL FISTULA; REMISSION; TREATMENT OUTCOME;

ABSCESS; ADULT; ANTIBODIES, MONOCLONAL; CROHN DISEASE; CUTANEOUS FISTULA; FEMALE; GASTROINTESTINAL AGENTS; HUMANS; INTESTINAL FISTULA; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; RISK FACTORS; SEPSIS; TREATMENT OUTCOME; VAGINAL FISTULA;

EID: 0037325450     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.2003.01427.x     Document Type: Article

References (14)

1. Farmer RG, Hawk WA, Turnbull RB Jr. Clinical patterns in Crohn's disease: a statistical study of 615 cases. Gastroenterology 1975; 68: 627-35.
2. Hellers G, Bergstrand O, Ewerth S, Holmstrom B. Occurrence and outcome after primary treatment of anal fistulae in Crohn's disease. Gut 1980; 21: 525-7.
3. Rankin GB, Watts HD, Melnyk CS, Kelley ML Jr. National Cooperative Crohn's Disease Study: extraintestinal manifestations and perianal complications. Gastroenterology 1979; 77: 914-20.
4. Steinberg DM, Cooke WT, Alexander-Williams J. Abscess and fistulae in Crohn's disease. Gut 1973; 14: 865-9.
5. Bell SJ, Williams AB, Wiesel P, Wilkinson K, Cohen RCG, Kamm MA. The natural history of fistulating Crohn's disease: prognosis is related to fistula anatomy. Gastroenterology 2002; 122(4): A610(Abstract).
6. Spencer JA, Ward J, Beckingham IJ, Adams C, Ambrose NS. Dynamic contrast-enhanced MR imaging of perianal fistulas. Am J Roentgenol 1996; 167: 735-41.
7. Present DH, Rutgeerts P, Targan S, et al. Infliximab for the treatment of fistulas in patients with Crohn's disease. N Engl J Med 1999; 340: 1398-405.
8. Van Assche G, Vanbeckevoort D, Coremans G, et al. MRI imaging of the effects of infliximab in perianal fistulizing Crohn's disease. Gastroenterology 2000; 118(6): A68(Abstract).
9. Rasul I, Wilson SR, Cohen Z, Greenberg GR. Infliximab therapy for Crohn's disease fistulae: discordance between perineal ultrasound findings and clinical response. Gastroenterology 2000; 118(16): A619(Abstract).
10. Schwartz DA, Wiersema MJ, Dudiak KM. et al. A comparison of endoscopic ultrasound, magnetic resonance imaging, and exam under anesthesia for evaluation of Crohn's perianal fistulas. Gastroenterology 2001; 121: 1064-72.
11. Beckingham IJ, Spencer JA, Ward J, et al. Prospective evaluation of dynamic contrast enhanced magnetic resonance imaging in the evaluation of fistula in ano. Br J Surg 1996; 83: 1396-8.
12. Chapple KS, Spencer JA, Windsor AC. et al. Prognostic value of magnetic resonance imaging in the management of fistula-in-ano. Dis Colon Rectum 2000; 43: 511-6.
13. Spencer JA, Chapple K, Wilson D, et al. Outcome after surgery for perianal fistula: predictive value of MR imaging. Am J Roentgenol 1998; 171: 403-6.
14. Halligan S. Imaging fistula in ano. Clin Radiol 1998; 53: 85-95.